Ultrasound could one day play a key role in drug delivery, if researchers can harness the ultrasound beam's cavitation effect, which allows drugs to pass through the protective membranes of cells.
Ultrasound could one day play a key role in drug delivery, if researchers can harness the ultrasound beam's cavitation effect, which allows drugs to pass through the protective membranes of cells.
Mark R. Prausnitz, Ph.D., of Georgia Institute of Technology's School of Chemical and Biomolecular Engineering experimented with living prostate cancer and animal cells. He confirmed that the powerful cavitation effect produces enough force to stimulate cell membrane permeability. The holes close down quickly but allow the entry of therapeutic molecules that are 50 nm in diameter, larger than most compounds used for gene therapy (J Ultras Med Bio 2006:32[6]915-924).
The procedure could find future use in systemic therapy in oncology, particularly for large-molecule drugs that cannot easily move through cell membranes.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.